why choose us

First received: May 12, 2023

Clinical Trial: BPL-003 Efficacy and Safety in Treatment Resistant Depression

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Treatment Resistant Depression

Study Type: INTERVENTIONAL


Official Title: A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, With Open Label Extension, in Patients With Treatment-Resistant Depression

Brief Summary: This is a Phase 2 study randomized, quadruple masked, multi-center study , with a Open Label Extension, designed to investigate the efficacy and safety of BPL-003 combined with psychological support in patients with treatment resistant depression (TRD).

Read more